Literature DB >> 17081768

Splenectomy changes the pattern of cytokine production in beta-thalassemic patients.

Ghollam-Reza Moshtaghi-Kashanian1, Ahmad Gholamhoseinian, Afrooz Hoseinimoghadam, Saeeid Rajabalian.   

Abstract

A major cause of morbidity and mortality in beta-thalassemic patients is infections, assumed to be the result of immunological changes. To determine the possible defect, we investigated the cytokine productions by blood cells of beta-thalassemic patients using in-vivo and in-vitro methods. Heparinized blood samples collected aseptically from 22 beta-thalassemic children aged 10-12yrs (half of them were splenectomized). Samples from 10 healthy children served as control group. Part of samples was used for evaluation of plasma IL-2, IL-10 and TGF-beta1. Other part were stimulated with a mixture of LPS and PHA (1 and 10 microg/ml final concentration), for different time period (4, 24, 48 and 72h). Results showed circulating TGF-beta1 of splenectomized patients was significantly higher (p<0.01) than the control group. In-vitro results showed IL-2 production of patients' groups were significantly (p<0.01) lower than corresponding value obtained for the control group. In addition, IL-10 production by splenectomized group were less than other two group (p<0.01), while their TGF-beta1 were higher (p<0.001) at all time points treated. In conclusion, multi-transfusions could be responsible for a change in the subset of circulating lymphocytes that could contribute to a state of partial immune deficiency in beta-thalassemic patients, which is more prominence among the splenectomized patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081768     DOI: 10.1016/j.cyto.2006.09.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major.

Authors:  Weili Bao; Hui Zhong; Xiaojuan Li; Margaret T Lee; Joseph Schwartz; Sujit Sheth; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2011-09-26       Impact factor: 10.047

2.  Bone loss caused by iron overload in a murine model: importance of oxidative stress.

Authors:  Jaime Tsay; Zheiwei Yang; F Patrick Ross; Susanna Cunningham-Rundles; Hong Lin; Rhima Coleman; Philipp Mayer-Kuckuk; Stephen B Doty; Robert W Grady; Patricia J Giardina; Adele L Boskey; Maria G Vogiatzi
Journal:  Blood       Date:  2010-06-16       Impact factor: 22.113

3.  Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the "high clinical risk" category?

Authors:  Mehran Karimi; Vincenzo De Sanctis
Journal:  Acta Biomed       Date:  2020-05-11

Review 4.  Ineffective erythropoiesis in β -thalassemia.

Authors:  Jean-Antoine Ribeil; Jean-Benoit Arlet; Michael Dussiot; Ivan Cruz Moura; Geneviève Courtois; Olivier Hermine
Journal:  ScientificWorldJournal       Date:  2013-03-28

5.  Splenectomy is modifying the vascular remodeling of thrombosis.

Authors:  Maria K Frey; Sherin Alias; Max P Winter; Bassam Redwan; Gerald Stübiger; Adelheid Panzenboeck; Arman Alimohammadi; Diana Bonderman; Johannes Jakowitsch; Helga Bergmeister; Valery Bochkov; Klaus T Preissner; Irene M Lang
Journal:  J Am Heart Assoc       Date:  2014-02-28       Impact factor: 5.501

6.  Assessment of serum zinc levels of patients with thalassemia compared to their siblings.

Authors:  Mohamed El Missiry; Mohamed Hamed Hussein; Sadaf Khalid; Naila Yaqub; Sarah Khan; Fatima Itrat; Cornelio Uderzo; Lawrence Faulkner
Journal:  Anemia       Date:  2014-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.